Management of type 2 diabetes in chronic kidney disease
The management of patients with type 2 diabetes and chronic kidney disease (CKD) encompasses lifestyle modifications, glycemic control with individualized HbA1c targets, and cardiovascular disease risk reduction. Metformin and sodium-glucose cotransporter-2 inhibitors are first-line agents. Glucagon...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021-03-01
|
| coleção: | BMJ Open Diabetes Research & Care |
| Acesso em linha: | https://drc.bmj.com/content/9/1/e002300.full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|